fenclonine has been researched along with Central Nervous System Disease in 1 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wardley-Smith, B | 1 |
| Hudson, S | 1 |
| Doré, CJ | 1 |
| Charlett, A | 1 |
| Fletcher, A | 1 |
| Brammer, NT | 1 |
| Minchin, MC | 1 |
| Wann, KT | 1 |
1 other study available for fenclonine and Central Nervous System Disease
| Article | Year |
|---|---|
Exposure to high pressure may produce the 5-HT behavioral syndrome in rats.
Topics: 5-Hydroxytryptophan; Animals; Atmospheric Pressure; Behavior, Animal; Brain; Carbidopa; Central Nerv | 1990 |